PubRank

Muin J Khoury

Author PubWeight™ 264.67‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Letting the genome out of the bottle--will we get our wish? N Engl J Med 2008 9.10
2 Deploying whole genome sequencing in clinical practice and public health: meeting the challenge one bin at a time. Genet Med 2011 8.48
3 Implications of small effect sizes of individual genetic variants on the design and interpretation of genetic association studies of complex diseases. Am J Epidemiol 2006 7.66
4 Systematic meta-analyses and field synopsis of genetic association studies in schizophrenia: the SzGene database. Nat Genet 2008 6.71
5 A navigator for human genome epidemiology. Nat Genet 2008 5.07
6 Assessment of cumulative evidence on genetic associations: interim guidelines. Int J Epidemiol 2007 4.96
7 Size matters: just how big is BIG?: Quantifying realistic sample size requirements for human genome epidemiology. Int J Epidemiol 2008 4.53
8 How many genes underlie the occurrence of common complex diseases in the population? Int J Epidemiol 2005 4.46
9 Comprehensive research synopsis and systematic meta-analyses in Parkinson's disease genetics: The PDGene database. PLoS Genet 2012 4.27
10 Sodium and potassium intake and mortality among US adults: prospective data from the Third National Health and Nutrition Examination Survey. Arch Intern Med 2011 4.22
11 Can family history be used as a tool for public health and preventive medicine? Genet Med 2002 3.76
12 National Institutes of Health approaches to dissemination and implementation science: current and future directions. Am J Public Health 2012 3.72
13 A critical appraisal of the scientific basis of commercial genomic profiles used to assess health risks and personalize health interventions. Am J Hum Genet 2008 3.25
14 Recommendations for returning genomic incidental findings? We need to talk! Genet Med 2013 3.23
15 A road map for efficient and reliable human genome epidemiology. Nat Genet 2006 3.21
16 What is the clinical utility of genetic testing? Genet Med 2006 3.01
17 Research priorities for evaluating family history in the prevention of common chronic diseases. Am J Prev Med 2003 2.99
18 Improving validation practices in "omics" research. Science 2011 2.73
19 Strengthening the reporting of genetic association studies (STREGA): an extension of the strengthening the reporting of observational studies in epidemiology (STROBE) statement. J Clin Epidemiol 2009 2.45
20 Family history in public health practice: a genomic tool for disease prevention and health promotion. Annu Rev Public Health 2010 2.43
21 STrengthening the REporting of Genetic Association Studies (STREGA): an extension of the STROBE statement. PLoS Med 2009 2.39
22 The impact of genotype frequencies on the clinical validity of genomic profiling for predicting common chronic diseases. Genet Med 2007 2.34
23 Tracking the epidemiology of human genes in the literature: the HuGE Published Literature database. Am J Epidemiol 2006 2.34
24 Most published research findings are false-but a little replication goes a long way. PLoS Med 2007 2.26
25 Family history and prevalence of diabetes in the U.S. population: the 6-year results from the National Health and Nutrition Examination Survey (1999-2004). Diabetes Care 2007 2.22
26 Developing Family Healthware, a family history screening tool to prevent common chronic diseases. Prev Chronic Dis 2008 2.20
27 Health care provider and consumer awareness, perceptions, and use of direct-to-consumer personal genomic tests, United States, 2008. Genet Med 2009 2.17
28 DNA banking for epidemiologic studies: a review of current practices. Epidemiology 2002 2.16
29 The path from genome-based research to population health: development of an international public health genomics network. Genet Med 2006 2.15
30 Invited commentary: genes, environment, and hybrid vigor. Am J Epidemiol 2009 2.15
31 Genomic profiling to promote a healthy lifestyle: not ready for prime time. Nat Genet 2003 2.11
32 Evolution of the "drivers" of translational cancer epidemiology: analysis of funded grants and the literature. Am J Epidemiol 2015 2.04
33 Future health applications of genomics: priorities for communication, behavioral, and social sciences research. Am J Prev Med 2010 1.98
34 Improving the prediction of complex diseases by testing for multiple disease-susceptibility genes. Am J Hum Genet 2003 1.85
35 Genomics and the prevention and control of common chronic diseases: emerging priorities for public health action. Prev Chronic Dis 2005 1.84
36 Required sample size and nonreplicability thresholds for heterogeneous genetic associations. Proc Natl Acad Sci U S A 2008 1.84
37 On the use of population attributable fraction to determine sample size for case-control studies of gene-environment interaction. Epidemiology 2003 1.82
38 STrengthening the REporting of Genetic Association studies (STREGA)--an extension of the STROBE statement. Eur J Clin Invest 2009 1.82
39 Awareness and utilization of BRCA1/2 testing among U.S. primary care physicians. Am J Prev Med 2011 1.80
40 From public health emergency to public health service: the implications of evolving criteria for newborn screening panels. Pediatrics 2006 1.77
41 Population-based study of the prevalence of family history of cancer: implications for cancer screening and prevention. Genet Med 2006 1.77
42 GAPscreener: an automatic tool for screening human genetic association literature in PubMed using the support vector machine technique. BMC Bioinformatics 2008 1.75
43 The next generation of large-scale epidemiologic research: implications for training cancer epidemiologists. Am J Epidemiol 2014 1.73
44 "Drivers" of translational cancer epidemiology in the 21st century: needs and opportunities. Cancer Epidemiol Biomarkers Prev 2013 1.72
45 Cancer GAMAdb: database of cancer genetic associations from meta-analyses and genome-wide association studies. Eur J Hum Genet 2011 1.69
46 Impact of violations and deviations in Hardy-Weinberg equilibrium on postulated gene-disease associations. Am J Epidemiol 2006 1.67
47 Family history of type 2 diabetes: a population-based screening tool for prevention? Genet Med 2006 1.67
48 Application of support vector machine modeling for prediction of common diseases: the case of diabetes and pre-diabetes. BMC Med Inform Decis Mak 2010 1.66
49 Challenges of translating genetic tests into clinical and public health practice. Nat Rev Genet 2009 1.62
50 The emergence of networks in human genome epidemiology: challenges and opportunities. Epidemiology 2007 1.61
51 Prevalence in the United States of selected candidate gene variants: Third National Health and Nutrition Examination Survey, 1991-1994. Am J Epidemiol 2008 1.53
52 Strengthening the reporting of genetic association studies (STREGA): an extension of the STROBE Statement. Hum Genet 2009 1.47
53 Strengthening the reporting of Genetic RIsk Prediction Studies (GRIPS): explanation and elaboration. J Clin Epidemiol 2011 1.46
54 A network of investigator networks in human genome epidemiology. Am J Epidemiol 2005 1.43
55 Does genetic testing really improve the prediction of future type 2 diabetes? PLoS Med 2006 1.43
56 Building the evidence base for decision making in cancer genomic medicine using comparative effectiveness research. Genet Med 2012 1.39
57 Implementing screening for Lynch syndrome among patients with newly diagnosed colorectal cancer: summary of a public health/clinical collaborative meeting. Genet Med 2011 1.37
58 Horizon scanning for new genomic tests. Genet Med 2011 1.36
59 The epidemiology of medium chain acyl-CoA dehydrogenase deficiency: an update. Genet Med 2006 1.35
60 Personal utility and genomic information: look before you leap. Genet Med 2009 1.32
61 Stakeholder assessment of the evidence for cancer genomic tests: insights from three case studies. Genet Med 2012 1.32
62 Gene Prospector: an evidence gateway for evaluating potential susceptibility genes and interacting risk factors for human diseases. BMC Bioinformatics 2008 1.31
63 Cancer pharmacogenomics and pharmacoepidemiology: setting a research agenda to accelerate translation. J Natl Cancer Inst 2010 1.30
64 Extending the reach of public health genomics: what should be the agenda for public health in an era of genome-based and “personalized” medicine? Genet Med 2010 1.27
65 Contribution of Mendelian disorders to common chronic disease: opportunities for recognition, intervention, and prevention. Am J Med Genet C Semin Med Genet 2004 1.25
66 Strengthening the reporting of genetic association studies (STREGA): an extension of the STROBE statement. Eur J Epidemiol 2009 1.25
67 An open source infrastructure for managing knowledge and finding potential collaborators in a domain-specific subset of PubMed, with an example from human genome epidemiology. BMC Bioinformatics 2007 1.24
68 Predictive genetic testing for type 2 diabetes. BMJ 2006 1.24
69 Knowledge integration in cancer: current landscape and future prospects. Cancer Epidemiol Biomarkers Prev 2012 1.19
70 Awareness and use of direct-to-consumer nutrigenomic tests, United States, 2006. Genet Med 2007 1.18
71 Is family history a useful tool for detecting children at risk for diabetes and cardiovascular diseases? A public health perspective. Pediatrics 2007 1.18
72 The arrival of genomic medicine to the clinic is only the beginning of the journey. Genet Med 2013 1.18
73 Evidence-based classification of recommendations on use of genomic tests in clinical practice: dealing with insufficient evidence. Genet Med 2010 1.17
74 Reporting of human genome epidemiology (HuGE) association studies: an empirical assessment. BMC Med Res Methodol 2008 1.17
75 Public awareness and use of direct-to-consumer personal genomic tests from four state population-based surveys, and implications for clinical and public health practice. Genet Med 2012 1.17
76 Public awareness and use of direct-to-consumer genetic tests: results from 3 state population-based surveys, 2006. Am J Public Health 2008 1.15
77 How can we stimulate translational research in cancer genomics beyond bench to bedside? Genet Med 2012 1.15
78 Familial risk assessment for early-onset coronary heart disease. Genet Med 2006 1.14
79 Using lifetime risk estimates in personal genomic profiles: estimation of uncertainty. Am J Hum Genet 2009 1.14
80 STrengthening the REporting of Genetic Association Studies (STREGA)--an extension of the STROBE statement. Genet Epidemiol 2009 1.13
81 Evaluation of the potential excess of statistically significant findings in published genetic association studies: application to Alzheimer's disease. Am J Epidemiol 2008 1.13
82 Evaluation of the validity and utility of genetic testing for rare diseases. Adv Exp Med Biol 2010 1.12
83 An automatic method to generate domain-specific investigator networks using PubMed abstracts. BMC Med Inform Decis Mak 2007 1.11
84 STrengthening the REporting of Genetic Association studies (STREGA): an extension of the STROBE Statement. Ann Intern Med 2009 1.11
85 Family history of heart disease and cardiovascular disease risk-reducing behaviors. Genet Med 2004 1.10
86 Strengthening the reporting of Genetic RIsk Prediction Studies: the GRIPS Statement. PLoS Med 2011 1.09
87 The role of genetic polymorphisms in environmental health. Environ Health Perspect 2003 1.09
88 GWAS Integrator: a bioinformatics tool to explore human genetic associations reported in published genome-wide association studies. Eur J Hum Genet 2011 1.08
89 The human genome project is complete. How do we develop a handle for the pump? Am J Epidemiol 2003 1.07
90 Accuracy of self-reported family history is strongly influenced by the accuracy of self-reported personal health status of relatives. J Clin Epidemiol 2011 1.07
91 The case for a global human genome epidemiology initiative. Nat Genet 2004 1.06
92 Evaluation of family history as a risk factor and screening tool for detecting undiagnosed diabetes in a nationally representative survey population. Genet Med 2006 1.06
93 Mendelian randomisation: a new spin or real progress? Lancet 2003 1.06
94 Improvements in ability to detect undiagnosed diabetes by using information on family history among adults in the United States. Am J Epidemiol 2010 1.05
95 Strengthening the reporting of genetic risk prediction studies: the GRIPS statement. Eur J Epidemiol 2011 1.04
96 Systems-based candidate genes for human response to influenza infection. Infect Genet Evol 2009 1.04
97 Collaborative biomedicine in the age of big data: the case of cancer. J Med Internet Res 2014 1.04
98 Genome Medicine: past, present and future. Genome Med 2011 1.03
99 Evaluation of the discriminative accuracy of genomic profiling in the prediction of common complex diseases. Eur J Hum Genet 2009 1.02
100 Racial/ethnic differences in association of fasting glucose-associated genomic loci with fasting glucose, HOMA-B, and impaired fasting glucose in the U.S. adult population. Diabetes Care 2010 1.01
101 A health services research agenda for cellular, molecular and genomic technologies in cancer care. Public Health Genomics 2009 1.01
102 Turning the pump handle: evolving methods for integrating the evidence on gene-disease association. Am J Epidemiol 2007 1.01
103 Assessment of improved prediction beyond traditional risk factors: when does a difference make a difference? Circ Cardiovasc Genet 2010 0.99
104 Race-ethnic differences in the association of genetic loci with HbA1c levels and mortality in U.S. adults: the third National Health and Nutrition Examination Survey (NHANES III). BMC Med Genet 2012 0.99
105 Recommendations and proposed guidelines for assessing the cumulative evidence on joint effects of genes and environments on cancer occurrence in humans. Int J Epidemiol 2012 0.99
106 Comparative effectiveness research in cancer genomics and precision medicine: current landscape and future prospects. J Natl Cancer Inst 2013 0.98
107 Genome-wide association studies in pharmacogenomics: untapped potential for translation. Genome Med 2009 0.98
108 Utilization of epidermal growth factor receptor (EGFR) testing in the United States: a case study of T3 translational research. Genet Med 2013 0.98
109 Discriminative accuracy of genomic profiling comparing multiplicative and additive risk models. Eur J Hum Genet 2010 0.97
110 Family history assessment to detect increased risk for colorectal cancer: conceptual considerations and a preliminary economic analysis. Cancer Epidemiol Biomarkers Prev 2005 0.97
111 Strengthening the reporting of genetic risk prediction studies (GRIPS): explanation and elaboration. Eur J Epidemiol 2011 0.94
112 Influence of familial risk on diabetes risk-reducing behaviors among U.S. adults without diabetes. Diabetes Care 2011 0.94
113 Prospective study of methylenetetrahydrofolate reductase (MTHFR) variant C677T and risk of all-cause and cardiovascular disease mortality among 6000 US adults. Am J Clin Nutr 2012 0.94
114 Opportunities and challenges for selected emerging technologies in cancer epidemiology: mitochondrial, epigenomic, metabolomic, and telomerase profiling. Cancer Epidemiol Biomarkers Prev 2012 0.94
115 From genetics to genomics: using gene-based medicine to prevent disease and promote health in children. Semin Perinatol 2005 0.93
116 Estimating the contribution of genetic variants to difference in incidence of disease between population groups. Eur J Hum Genet 2012 0.93
117 The continued need to synthesize the results of genetic associations across multiple studies. Genet Med 2008 0.93
118 Collaborative cancer epidemiology in the 21st century: the model of cancer consortia. Cancer Epidemiol Biomarkers Prev 2013 0.92
119 HFE genotype and transferrin saturation in the United States. Genet Med 2003 0.91
120 The geometric increase in meta-analyses from China in the genomic era. PLoS One 2013 0.91
121 Expanding the definition of a positive family history for early-onset coronary heart disease. Genet Med 2006 0.91
122 Strengthening the reporting of genetic risk prediction studies: the GRIPS statement. Eur J Clin Invest 2011 0.91
123 Public health genomics: translating obesity genomics research into population health benefits. Obesity (Silver Spring) 2008 0.90
124 Health beliefs among individuals at increased familial risk for type 2 diabetes: implications for prevention. Diabetes Res Clin Pract 2012 0.89
125 PLoS currents: evidence on genomic tests - At the crossroads of translation. PLoS Curr 2010 0.89
126 Prevalence, family history, and prevention of reported osteoporosis in U.S. women. Am J Prev Med 2008 0.88
127 The need for genetic variant naming standards in published abstracts of human genetic association studies. BMC Res Notes 2009 0.87
128 Strengthening the reporting of genetic risk prediction studies: the GRIPS statement. BMJ 2011 0.87
129 Evidence based medicine meets genomic medicine. Genet Med 2007 0.85
130 Strengthening the reporting of Genetic Risk Prediction Studies: the GRIPS statement. Genet Med 2011 0.85
131 Strengthening the reporting of genetic risk prediction studies (GRIPS): explanation and elaboration. Eur J Clin Invest 2011 0.85
132 Steroid 5-{alpha}-reductase Type 2 (SRD5a2) gene polymorphisms and risk of prostate cancer: a HuGE review. Am J Epidemiol 2009 0.85
133 Reporting of systematic reviews: the challenge of genetic association studies. PLoS Med 2007 0.85
134 The association between family history of asthma and the prevalence of asthma among US adults: National Health and Nutrition Examination Survey, 1999-2004. Genet Med 2009 0.84
135 What is translational genomics? An expanded research agenda for improving individual and population health. Appl Transl Genom 2014 0.84
136 Public knowledge regarding the role of genetic susceptibility to environmentally induced health conditions. Community Genet 2003 0.83
137 A public health approach to pharmacogenomics and gene-based diagnostic tests. Pharmacogenomics 2006 0.83
138 Make it HuGE: human genome epidemiology reviews, population health, and the IJE. Int J Epidemiol 2006 0.83
139 The epidemiologic approach to pharmacogenomics. Am J Pharmacogenomics 2005 0.83
140 Family history as a risk factor for early-onset stroke/transient ischemic attack among adults in the United States. Public Health Genomics 2009 0.82
141 Strengthening the reporting of genetic risk prediction studies: The GRIPS Statement. Ann Intern Med 2011 0.82
142 Comparative effectiveness research in cancer: what has been funded and what knowledge gaps remain? J Natl Cancer Inst 2013 0.82
143 Assessing causal relationships in genomics: From Bradford-Hill criteria to complex gene-environment interactions and directed acyclic graphs. Emerg Themes Epidemiol 2011 0.82
144 Family history and prevalence of diabetes in the US population: 6-year results from the National Health and Nutrition Examination Survey (NHANES, 1999 2004). Diabetes 2007 0.82
145 Predictive genetic testing for the identification of high-risk groups: a simulation study on the impact of predictive ability. Genome Med 2011 0.81
146 Sample size requirements to detect the effect of a group of genetic variants in case-control studies. Emerg Themes Epidemiol 2008 0.81
147 Genetic associations with metabolic syndrome and its quantitative traits by race/ethnicity in the United States. Metab Syndr Relat Disord 2011 0.81
148 A primer series on -omic technologies for the practice of epidemiology. Am J Epidemiol 2014 0.81
149 Five genetic variants associated with prostate cancer. N Engl J Med 2008 0.81
150 Provocative questions in cancer epidemiology in a time of scientific innovation and budgetary constraints. Cancer Epidemiol Biomarkers Prev 2013 0.80
151 Primary immunodeficiency diseases: practice among primary care providers and awareness among the general public, United States, 2008. Genet Med 2010 0.80
152 The impact of early cystic fibrosis diagnosis on pulmonary function in children. J Pediatr 2002 0.80
153 Looking back at genomic medicine in 2011. Genome Med 2012 0.79
154 Strengthening the reporting of genetic risk prediction studies (GRIPS): explanation and elaboration. Eur J Hum Genet 2011 0.79
155 A Hardy-Weinberg equilibrium test for analyzing population genetic surveys with complex sample designs. Am J Epidemiol 2010 0.79
156 The emergence of biobanks: practical design considerations for large population-based studies of gene-environment interactions. Community Genet 2007 0.79
157 Strengthening the reporting of genetic risk prediction studies: the GRIPS statement. Eur J Hum Genet 2011 0.78
158 Epigenetic research in cancer epidemiology: trends, opportunities, and challenges. Cancer Epidemiol Biomarkers Prev 2013 0.78
159 Genetic association studies of cancer: where do we go from here? Cancer Epidemiol Biomarkers Prev 2007 0.78
160 Genomics and public health research. JAMA 2007 0.77
161 The integration of genomics into obstetrics and gynecology: a HuGE challenge. Am J Obstet Gynecol 2006 0.77
162 Editorial: Updated guidance on human genome epidemiology (HuGE) reviews and meta-analyses of genetic associations. Am J Epidemiol 2014 0.77
163 An empirical comparison of meta-analyses of published gene-disease associations versus consortium analyses. Genet Med 2009 0.77
164 Planning for the Future of Epidemiology in the Era of Big Data and Precision Medicine. Am J Epidemiol 2015 0.77
165 Genomics and public health in the United States: signposts on the translation highway. Community Genet 2006 0.77
166 Genomics, epidemiology, and common complex diseases: let's not throw out the baby with the bathwater! Int J Epidemiol 2006 0.77
167 Building a knowledge base on genetic variation and cancer risk through field synopses. J Natl Cancer Inst 2008 0.75
168 Lam et al. respond to "Driving for further evolution". Am J Epidemiol 2015 0.75
169 Correspondence to Sand et Al. "Critical reappraisal of a catechol-o-methyltransferase transversion variant in schizophrenia". Biol Psychiatry 2010 0.75
170 Expanded publishing model for genetic association studies. Cancer Epidemiol Biomarkers Prev 2006 0.75
171 Dermatology and the human genome: an epidemiologic approach. Arch Dermatol 2007 0.75
172 Strengthening the reporting of genetic risk prediction studies: the GRIPS statement. Genome Med 2011 0.75
173 Helping high-risk families: medical and public health approaches. Genet Med 2002 0.75
174 Human Genome Sequencing at the Population Scale: A Primer on High-Throughput DNA Sequencing and Analysis. Am J Epidemiol 2017 0.75
175 Q&A: Muin Khoury on cancer epidemiology. Cancer Discov 2014 0.75
176 Editorial: Emergence of Gene-Environment Interaction Analysis in Epidemiologic Research. Am J Epidemiol 2017 0.75
177 Combining molecular and genetic data from different sources. IARC Sci Publ 2011 0.75
178 Strengthening the reporting of genetic risk prediction studies: the GRIPS statement. Circ Cardiovasc Genet 2011 0.75
179 Strengthening the reporting of Genetic RIsk Prediction Studies: the GRIPS Statement. J Clin Epidemiol 2011 0.75
180 CDC Grand Rounds: Family History and Genomics as Tools for Cancer Prevention and Control. MMWR Morb Mortal Wkly Rep 2016 0.75
181 Research priorities for public health sciences in the postgenomic era. Genet Med 2003 0.75
182 Introduction to the 4th National Conference on Genomics and Public Health. Public Health Genomics 2012 0.75